Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Shapiro

Showing results (941-950 of 1,171) with videos related to

Pageof 118
Sort By:
Journal for Immunotherapy of Cancer|June 20, 2020
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE<sub>2</sub>-receptor E-type 4 (EP4), in patients with advanced cancersDavid S Hong, Aparna Parikh, Geoffrey I Shapiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2017
A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i>-Mutated Ovarian Carcinoma or Other Solid TumorsRebecca Kristeleit, Geoffrey I Shapiro, Howard A Burris, et al.
Nature Communications|January 6, 2025
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trialMrinal Gounder, Melissa Johnson, Rebecca S Heist, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Disruption of Microhomology-mediated End-joining in Ewing SarcomaShuhei Asada, Guangli Zhu, Jithma Prasad Abeykoon, et al.
JCO Precision Oncology|October 24, 2024
Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis CarcinomaGianna Kroening, Jia Luo, Mark G Evans, et al.
JAMA Network Open|January 16, 2019
Effect of Levocarnitine vs Placebo as an Adjunctive Treatment for Septic Shock: The Rapid Administration of Carnitine in Sepsis (RACE) Randomized Clinical TrialAlan E Jones, Michael A Puskarich, Nathan I Shapiro, et al.
JAMA Psychiatry|November 3, 2016
Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal StudyLarry J Seidman, Daniel I Shapiro, William S Stone, et al.
Early Intervention in Psychiatry|January 7, 2026
Feasibility of a Stepped-Care Intervention for Those at Clinical High Risk for Psychosis in the United StatesDaniel I Shapiro, Rebecca E Grattan, Jill R Laquidara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2012
Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancerTakeshi Shimamura, Samanthi A Perera, Kevin P Foley, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 29, 2022
Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trialAlexander M Kaizer, Nathan I Shapiro, Jessica Wild, et al.
Pageof 118

Showing results (941-950 of 1,171) with videos related to

Sort By:
Pageof 118
Journal for Immunotherapy of Cancer|June 20, 2020
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE<sub>2</sub>-receptor E-type 4 (EP4), in patients with advanced cancersDavid S Hong, Aparna Parikh, Geoffrey I Shapiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2017
A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i>-Mutated Ovarian Carcinoma or Other Solid TumorsRebecca Kristeleit, Geoffrey I Shapiro, Howard A Burris, et al.
Nature Communications|January 6, 2025
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trialMrinal Gounder, Melissa Johnson, Rebecca S Heist, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Disruption of Microhomology-mediated End-joining in Ewing SarcomaShuhei Asada, Guangli Zhu, Jithma Prasad Abeykoon, et al.
JCO Precision Oncology|October 24, 2024
Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis CarcinomaGianna Kroening, Jia Luo, Mark G Evans, et al.
JAMA Network Open|January 16, 2019
Effect of Levocarnitine vs Placebo as an Adjunctive Treatment for Septic Shock: The Rapid Administration of Carnitine in Sepsis (RACE) Randomized Clinical TrialAlan E Jones, Michael A Puskarich, Nathan I Shapiro, et al.
JAMA Psychiatry|November 3, 2016
Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal StudyLarry J Seidman, Daniel I Shapiro, William S Stone, et al.
Early Intervention in Psychiatry|January 7, 2026
Feasibility of a Stepped-Care Intervention for Those at Clinical High Risk for Psychosis in the United StatesDaniel I Shapiro, Rebecca E Grattan, Jill R Laquidara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2012
Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancerTakeshi Shimamura, Samanthi A Perera, Kevin P Foley, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 29, 2022
Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trialAlexander M Kaizer, Nathan I Shapiro, Jessica Wild, et al.
Pageof 118